338 related articles for article (PubMed ID: 9606376)
61. MR imaging of the gastrointestinal tract with i.v., gadolinium and diluted barium oral contrast media compared with unenhanced MR imaging and CT.
Low RN; Francis IR
AJR Am J Roentgenol; 1997 Oct; 169(4):1051-9. PubMed ID: 9308464
[TBL] [Abstract][Full Text] [Related]
62. Blood-pool MR contrast material for detection and characterization of focal hepatic lesions: initial clinical experience with ultrasmall superparamagnetic iron oxide (AMI-227).
Saini S; Edelman RR; Sharma P; Li W; Mayo-Smith W; Slater GJ; Eisenberg PJ; Hahn PF
AJR Am J Roentgenol; 1995 May; 164(5):1147-52. PubMed ID: 7717222
[TBL] [Abstract][Full Text] [Related]
63. [Use of SPIO-enhanced T1- and T2-weighted images for the differentiation of liver lesions: an ROC analysis].
Stroszczynski C; Gaffke G; Gretschel S; Rambow A; Jost D; Schlecht I; Schneider U; Schicke B; Hohenberger P; Gebauer B; Felix R
Rofo; 2003 Oct; 175(10):1368-75. PubMed ID: 14556106
[TBL] [Abstract][Full Text] [Related]
64. Diffuse liver hamartomatosis (diffuse von Meyenburg complexes) mimicking hepatic metastases on a background of previous cancer.
Monteiro de Barros J; Stell D; Bracey TS; Mavroeidis VK
Ann R Coll Surg Engl; 2020 Nov; 102(9):e1-e4. PubMed ID: 32734771
[TBL] [Abstract][Full Text] [Related]
65. Spectrum of multilocular cystic hepatic lesions: CT and MR imaging findings with pathologic correlation.
Qian LJ; Zhu J; Zhuang ZG; Xia Q; Liu Q; Xu JR
Radiographics; 2013; 33(5):1419-33. PubMed ID: 24025933
[TBL] [Abstract][Full Text] [Related]
66. Aberrant gastric venous drainage in cirrhotic livers: imaging findings in focal areas of liver parenchyma.
Matsui O; Kadoya M; Yoshikawa J; Gabata T; Takahashi S; Ueda K; Kawamori Y; Takashima T; Nakanuma Y
Radiology; 1995 Nov; 197(2):345-9. PubMed ID: 7480675
[TBL] [Abstract][Full Text] [Related]
67. Small arterial-portal venous shunts: a cause of pseudolesions at hepatic imaging.
Yu JS; Kim KW; Sung KB; Lee JT; Yoo HS
Radiology; 1997 Jun; 203(3):737-42. PubMed ID: 9169697
[TBL] [Abstract][Full Text] [Related]
68. Early-enhancing nonneoplastic lesions on gadolinium-enhanced magnetic resonance imaging of the liver following partial hepatectomy.
Goshima S; Kanematsu M; Matsuo M; Kondo H; Yokoyama R; Hoshi H; Moriyama N
J Magn Reson Imaging; 2004 Jul; 20(1):66-74. PubMed ID: 15221810
[TBL] [Abstract][Full Text] [Related]
69. Inflammatory pseudotumor of the liver: appearance on contrast enhanced helical CT and dynamic MR images.
Kelekis NL; Warshauer DM; Semelka RC; Eisenberg LB; Woosley JT
J Magn Reson Imaging; 1995; 5(5):551-3. PubMed ID: 8574040
[TBL] [Abstract][Full Text] [Related]
70. Mesenchymal hamartomas of the chest wall in infancy: radiologic and pathologic correlation.
Kim JY; Jung WH; Yoon CS; Kim MJ; Kim HK; Kim KD; Cho SH
Yonsei Med J; 2000 Oct; 41(5):615-22. PubMed ID: 11079622
[TBL] [Abstract][Full Text] [Related]
71. [Imaging of cystic liver diseases].
Precetti S; Gandon Y; Vilgrain V
J Radiol; 2007; 88(7-8 Pt 2):1061-72. PubMed ID: 17762835
[TBL] [Abstract][Full Text] [Related]
72. Imaging features of bile duct adenoma: case series and review of literature.
Chuy JA; Garg I; Graham RP; VanBuren WM; Venkatesh SK
Diagn Interv Radiol; 2018 Sep; 24(5):249-254. PubMed ID: 30211677
[TBL] [Abstract][Full Text] [Related]
73. Cholangiocarcinoma arising in von Meyenburg complexes: report of four cases.
Song JS; Lee YJ; Kim KW; Huh J; Jang SJ; Yu E
Pathol Int; 2008 Aug; 58(8):503-12. PubMed ID: 18705771
[TBL] [Abstract][Full Text] [Related]
74. [Value of computed tomography and magnetic resonance imaging in diagnosis and differential diagnosis of small hepatocellular carcinoma].
Ma Y; Zhang XL; Li XY; Zhang L; Su HH; Zhan CY
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Dec; 28(12):2235-8. PubMed ID: 19114368
[TBL] [Abstract][Full Text] [Related]
75. CT and MR appearances of splenic hamartoma.
Ohtomo K; Fukuda H; Mori K; Minami M; Itai Y; Inoue Y
J Comput Assist Tomogr; 1992; 16(3):425-8. PubMed ID: 1592926
[TBL] [Abstract][Full Text] [Related]
76. Detecting hepatocellular carcinoma: value of unenhanced or arterial phase CT imaging or both used in conjunction with conventional portal venous phase contrast-enhanced CT imaging.
Oliver JH; Baron RL; Federle MP; Rockette HE
AJR Am J Roentgenol; 1996 Jul; 167(1):71-7. PubMed ID: 8659425
[TBL] [Abstract][Full Text] [Related]
77. Hepatoportal sclerosis: CT and MRI appearance with histopathologic correlation.
Krishnan P; Fiel MI; Rosenkrantz AB; Hajdu CH; Schiano TD; Oyfe I; Taouli B
AJR Am J Roentgenol; 2012 Feb; 198(2):370-6. PubMed ID: 22268180
[TBL] [Abstract][Full Text] [Related]
78. Diagnostic accuracy of magnetic resonance, computed tomography and contrast enhanced ultrasound in radiological multimodality assessment of peribiliary liver metastases.
Granata V; Fusco R; Catalano O; Avallone A; Palaia R; Botti G; Tatangelo F; Granata F; Cascella M; Izzo F; Petrillo A
PLoS One; 2017; 12(6):e0179951. PubMed ID: 28632786
[TBL] [Abstract][Full Text] [Related]
79. The hepatic von Meyenburg complex: prevalence and association with hepatic and renal cysts among 2843 autopsies [corrected].
Redston MS; Wanless IR
Mod Pathol; 1996 Mar; 9(3):233-7. PubMed ID: 8685220
[TBL] [Abstract][Full Text] [Related]
80. Distinguishing hypervascular pseudolesions of the liver from hypervascular hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging.
Motosugi U; Ichikawa T; Sou H; Sano K; Tominaga L; Muhi A; Araki T
Radiology; 2010 Jul; 256(1):151-8. PubMed ID: 20574092
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
